GB202115200D0 - Retentive formulation - Google Patents
Retentive formulationInfo
- Publication number
- GB202115200D0 GB202115200D0 GBGB2115200.4A GB202115200A GB202115200D0 GB 202115200 D0 GB202115200 D0 GB 202115200D0 GB 202115200 A GB202115200 A GB 202115200A GB 202115200 D0 GB202115200 D0 GB 202115200D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- retentive formulation
- retentive
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2115200.4A GB202115200D0 (en) | 2021-10-22 | 2021-10-22 | Retentive formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2115200.4A GB202115200D0 (en) | 2021-10-22 | 2021-10-22 | Retentive formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202115200D0 true GB202115200D0 (en) | 2021-12-08 |
Family
ID=78805957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2115200.4A Ceased GB202115200D0 (en) | 2021-10-22 | 2021-10-22 | Retentive formulation |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202115200D0 (en) |
-
2021
- 2021-10-22 GB GBGB2115200.4A patent/GB202115200D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202008303D0 (en) | Therapeutic compositions | |
IL285674A (en) | Pharmaceutical formulations | |
IL290894A (en) | Pharmaceutical formulation | |
GB202007546D0 (en) | Formulation | |
GB202010230D0 (en) | Pharmaceutical formulation | |
IL297081A (en) | Pharmaceutical formulation | |
GB202018889D0 (en) | Formulations | |
GB202115200D0 (en) | Retentive formulation | |
GB202009684D0 (en) | Formulations | |
GB201906473D0 (en) | Pharmaceutical formulation | |
GB201905878D0 (en) | Retentive formulation | |
IL305977A (en) | Formulation comprising ceralasertib | |
IL307849A (en) | Sotorasib formulation | |
IL308046A (en) | Alpelisib formulation | |
GB202108165D0 (en) | Formulation | |
GB202107439D0 (en) | Formulation | |
GB202107203D0 (en) | Formulation | |
GB202103970D0 (en) | Formulation | |
GB202102636D0 (en) | Formulation | |
GB202102408D0 (en) | Formulation | |
GB202016274D0 (en) | Formulation | |
ZA202212663B (en) | Pharmaceutical formulations | |
GB202010573D0 (en) | Formulation | |
IL308250A (en) | Pharmaceutical formulations | |
GB202006008D0 (en) | Aerosolisable formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |